Researchers look ahead to the potential uses and benefits of a technology that has been more than 20 years in the making. Elie Dolgin Self-amplifying RNA vaccines will add to the arsenal of conventional messenger RNA jabs.Credit: Pascal Pochard-Casabianca/AFP via Getty The approval of yet another RNA-based vaccine for COVID-19 might not seem momentous. But...